D-0634-2018 Class II Terminated

Recalled by Partell Specialty Pharmacy — Las Vegas, NV

FDA drug recall D-0634-2018 was initiated by Partell Specialty Pharmacy on Mar 22, 2018 and is designated Class II. Reason for recall: Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. The recall status is terminated (terminated Jan 15, 2019). Affected quantity: 4 vials.

Recall Details

Product Type
Drugs
Report Date
Apr 25, 2018
Initiation Date
Mar 22, 2018
Termination Date
Jan 15, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 vials

Product Description

Ascorbic Acid (Tapioca) 500 mg/mL, 50 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800

Reason for Recall

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Distribution Pattern

NV only

Code Information

Lot#: 20180201@34, BUD 04/02/2018; 20180202@56, BUD 04/03/2018; 20180129@41, BUD 3/30/2018; 20180207@16, BUD 04/08/2018.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0634-2018
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.